SEC Form 4 · accession 0000899243-16-029944
BIODELIVERY SCIENCES INTERNATIONAL INC · BDSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Francis E Odonnell Jr.
Director
Period of report
Sep 22, 2016
Accepted (ET)
Sep 23, 2016 · 6:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001103021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Sep 22, 2016 | S | 50,000 | $2.45 | D | 1,335,490 | I | By HCG II, LLC |
| Common StockF4,F2,F3 | Sep 23, 2016 | S | 50,000 | $2.68 | D | 1,285,490 | I | By HCG II, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On September 22, 2016, Hopkins Capital Group II, LLC ("HCGII") sold an aggregate of 50,000 shares of the Issuer's Common Stock at a weighted average price of $2.45 per share. The highest sale price for the Common Stock was $2.47 per share and the lowest sale price was $2.43 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2Represents all of the shares of the Issuer held by HCGII.
- F3The shares are owned by HCGII. The Reporting Person is a discretionary beneficiary of an irrevocable spendthrift trust which directly owns a minority membership interest in HCGII. The Reporting Person disclaims ownership of all securities held by HCGII.
- F4On September 23, 2016, HCGII sold an aggregate of 50,000 shares of the Issuer's Common Stock at a weighted average price of $2.68 per share. The highest sale price for the Common Stock was $2.81 per share and the lowest sale price was $2.58 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.